E-LIB Suche - Ergebnisse für: Döhner, C

1

Defining and evaluating quality for ambulatory care educati..:

Bowen, J L ; Stearns, J A ; Dohner, C..
Academic Medicine. 72 (1997) 6 - p. 506-10 , 1997

Link: https://doi.org/10.1097/..

2

Independent study in medical science:

Dohner, C W ; Hunt, D D
Academic Medicine. 64 (1989) 11 - p. 653-4 , 1989

Link: https://doi.org/10.1097/..

3

Reply by Authors to C. A. Willis:

BRUNNER, M. J. ; DOHNER, C. V. ; LAWIT, R. L.
Journal of Spacecraft and Rockets. 6 (1969) 7 - p. 0864b-0864b , 1969

Link: https://doi.org/10.2514/..

4

Re-entry of radioactive power sources:

BRUNNER, M. J. ; DOHNER, C. V. ; LAWIT, R. L.
Journal of Spacecraft and Rockets. 5 (1968) 4 - p. 448-453 , 1968

Link: https://doi.org/10.2514/..

5

Diabetic myocardial disorder. A clinical consensus statemen..:

Seferović, Petar M. ; Paulus, Walter J. ; Rosano, Giuseppe...
European Journal of Heart Failure. , 2024

Link: https://doi.org/10.1002/..

6

Clinicohematologic and molecular response of essential thro..:

Stegelmann, Frank ; Teichmann, Lino L. ; Heidel, Florian H....
Leukemia. 37 (2023) 4 - p. 924-928 , 2023

Link: https://doi.org/10.1038/..

7

POSTER: AML-469 Ivosidenib + Azacitidine vs Placebo + Azaci..:

de Botton, Stéphane ; Montesinos, Pau ; Polo, Susana Vives...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S166 , 2023

Link: https://doi.org/10.1016/..

8

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 ..:

Hammersen, J. ; Birndt, S. ; Döhner, K....
Leukemia. 37 (2023) 9 - p. 1879-1886 , 2023

Link: https://doi.org/10.1038/..

9

The role of nuclear pores and importins for herpes simplex ..:

Döhner, Katinka ; Serrero, Manutea C ; Sodeik, Beate
Current Opinion in Virology. 62 (2023) - p. 101361 , 2023

Link: https://doi.org/10.1016/..

10

Long‐term survival with oral azacitidine for patients with ..:

Wei, Andrew H. ; Döhner, Hartmut ; Sayar, Hamid...
American Journal of Hematology. 98 (2023) 4 - p. , 2023

Link: https://doi.org/10.1002/..

11

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome a..:

Kuendgen, A. ; Nomdedeu, M. ; Tuechler, H....
Leukemia Research. 128 (2023) - p. 107226 , 2023

Link: https://doi.org/10.1016/..

12

Experience With IVDR Implementation in Three Diagnostic Lab..:

Lubbers, Bart R. ; Dombrink, Isabel ; Kalina, Tomas...
HemaSphere. 7 (2023) 4 - p. e865 , 2023

Link: https://doi.org/10.1097/..

13

The German Network for Personalized Medicine to enhance pat..:

Illert, A. L. ; Stenzinger, A. ; Bitzer, M....
Nature Medicine. 29 (2023) 6 - p. 1298-1301 , 2023

Link: https://doi.org/10.1038/..

14

Enasidenib vs conventional care in older patients with late..:

de Botton, Stéphane ; Montesinos, Pau ; Schuh, Andre C....
Blood. 141 (2023) 2 - p. 156-167 , 2023

Link: https://doi.org/10.1182/..

15

AML-469 Ivosidenib + Azacitidine vs Placebo + Azacitidine i..:

de Botton, Stéphane ; Montesinos, Pau ; Polo, Susana Vives...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S304 , 2023

Link: https://doi.org/10.1016/..